eyeGENE: The National Ophthalmic Genotyping and Phenotyping Network

Other names: eyeGENE, EyeGENE, The National Ophthalmic Genotyping and Phenotyping Network

The National Ophthalmic Disease Genotyping and Phenotyping Network (eyeGENE®) is a genomic medicine initiative created by the National Eye Institute (NEI), part of the National Institutes of Health (NIH), in partnership with clinics and laboratories across the vision research community. The core mission of eyeGENE® is to facilitate research into the causes and mechanisms of rare inherited eye diseases and accelerate pathways to treatments. eyeGENE® was designed to achieve this goal through clinical and molecular diagnosis coupled with granting controlled access to clinical and genetic information in a data repository, to DNA in a biorepository, and to individuals consented to participate in research and clinical trials. The eyeGENE® Network currently includes a Coordinating Center at the NEI, CLIA†-approved molecular genetic testing laboratories around the Nation, a patient registry, controlled-access centralized biorepository for DNA, and a curated de-identified genotype / phenotype database. These components stimulate patient and eye health care provider interest in genetics-based clinical care and generate involvement in ophthalmic research, thereby accelerating vision research and treatment development for these diseases.

Webpage:
https://eyegene.nih.gov

Licence:
Name: other
URL: https://eyegene.nih.gov/sites/eyegene.cit.nih.gov.nei/files/inline-files/Master-eyeGENE-Stage-2-Master-MTA-v2-clean.pdf

Publications:

Tags:

disease dna samples cataracts clinical trial corneal dystrophies data informatics genetics genotypes glaucoma health care medicine ocular disease pathways to treatments phenotypes retinal degenerations strabismus

More to explore:

1/20

Previous Next   



Need help integrating and/or managing biomedical data?